GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

FAIR Health data released this month showed more than 2% of adult patients now take a GLP-1 drug to treat overweight or obesity. Among all adult patients, the percentage who had an overweight or ...

HTP, Chromium and More Now Available to Help Promote Appetite Control and Metabolic BalanceNew York, June 24, 2025 (GLOBE ...

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

A $10.2 million savings across more than 100,000 prescriptions over three months, extrapolated across the nearly 33 million Americans currently taking GLP-1 medications monthly, indicates a potential ...

An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with ...

Mean body weight reductions after 24 weeks ranged from 8.2% to 10.3% in the MDR-001 cohorts, versus 2.5% in the placebo arm.

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

Hims & Hers delivered record Q1 results and expanded into Europe with the Zava acquisition. Click here to see why HIMS stock is a Hold.

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...